nodes	percent_of_prediction	percent_of_DWPC	metapath
Naproxen—Ibuprofen—Melphalan—peripheral nervous system neoplasm	0.377	1	CrCrCtD
Naproxen—AKR1C3—Doxorubicin—peripheral nervous system neoplasm	0.107	0.261	CbGbCtD
Naproxen—UGT2B7—Epirubicin—peripheral nervous system neoplasm	0.0628	0.153	CbGbCtD
Naproxen—UGT1A1—Etoposide—peripheral nervous system neoplasm	0.0423	0.103	CbGbCtD
Naproxen—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0294	0.0719	CbGbCtD
Naproxen—PTGS2—Cisplatin—peripheral nervous system neoplasm	0.0259	0.0632	CbGbCtD
Naproxen—PTGS2—Etoposide—peripheral nervous system neoplasm	0.0254	0.0621	CbGbCtD
Naproxen—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0245	0.0599	CbGbCtD
Naproxen—PTGS1—Etoposide—peripheral nervous system neoplasm	0.0215	0.0524	CbGbCtD
Naproxen—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0205	0.0501	CbGbCtD
Naproxen—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0196	0.0479	CbGbCtD
Naproxen—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0124	0.0302	CbGbCtD
Naproxen—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.00958	0.0234	CbGbCtD
Naproxen—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.00879	0.0215	CbGbCtD
Naproxen—AKR1C3—Podofilox—Etoposide—peripheral nervous system neoplasm	0.00178	0.592	CbGdCrCtD
Naproxen—AKR1C3—Vinblastine—Vincristine—peripheral nervous system neoplasm	0.00122	0.408	CbGdCrCtD
Naproxen—Pneumonia—Epirubicin—peripheral nervous system neoplasm	5.19e-05	0.000247	CcSEcCtD
Naproxen—Drowsiness—Epirubicin—peripheral nervous system neoplasm	5.16e-05	0.000245	CcSEcCtD
Naproxen—Vomiting—Dactinomycin—peripheral nervous system neoplasm	5.16e-05	0.000245	CcSEcCtD
Naproxen—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	5.15e-05	0.000245	CcSEcCtD
Naproxen—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	5.15e-05	0.000245	CcSEcCtD
Naproxen—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	5.12e-05	0.000243	CcSEcCtD
Naproxen—Rash—Dactinomycin—peripheral nervous system neoplasm	5.12e-05	0.000243	CcSEcCtD
Naproxen—Decreased appetite—Etoposide—peripheral nervous system neoplasm	5.11e-05	0.000243	CcSEcCtD
Naproxen—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	5.09e-05	0.000242	CcSEcCtD
Naproxen—Renal failure—Epirubicin—peripheral nervous system neoplasm	5.07e-05	0.000241	CcSEcCtD
Naproxen—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	5.07e-05	0.000241	CcSEcCtD
Naproxen—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	5.07e-05	0.000241	CcSEcCtD
Naproxen—Fatigue—Etoposide—peripheral nervous system neoplasm	5.06e-05	0.000241	CcSEcCtD
Naproxen—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	5.06e-05	0.000241	CcSEcCtD
Naproxen—Stomatitis—Epirubicin—peripheral nervous system neoplasm	5.03e-05	0.000239	CcSEcCtD
Naproxen—Jaundice—Epirubicin—peripheral nervous system neoplasm	5.03e-05	0.000239	CcSEcCtD
Naproxen—Pain—Etoposide—peripheral nervous system neoplasm	5.02e-05	0.000239	CcSEcCtD
Naproxen—Constipation—Etoposide—peripheral nervous system neoplasm	5.02e-05	0.000239	CcSEcCtD
Naproxen—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	5.02e-05	0.000239	CcSEcCtD
Naproxen—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	5.02e-05	0.000239	CcSEcCtD
Naproxen—Dysuria—Doxorubicin—peripheral nervous system neoplasm	5.01e-05	0.000238	CcSEcCtD
Naproxen—Dizziness—Alitretinoin—peripheral nervous system neoplasm	4.98e-05	0.000237	CcSEcCtD
Naproxen—Diarrhoea—Vincristine—peripheral nervous system neoplasm	4.96e-05	0.000236	CcSEcCtD
Naproxen—Sweating—Epirubicin—peripheral nervous system neoplasm	4.95e-05	0.000235	CcSEcCtD
Naproxen—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	4.95e-05	0.000235	CcSEcCtD
Naproxen—Haematuria—Epirubicin—peripheral nervous system neoplasm	4.92e-05	0.000234	CcSEcCtD
Naproxen—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	4.89e-05	0.000233	CcSEcCtD
Naproxen—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	4.88e-05	0.000232	CcSEcCtD
Naproxen—Epistaxis—Epirubicin—peripheral nervous system neoplasm	4.87e-05	0.000232	CcSEcCtD
Naproxen—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	4.85e-05	0.00023	CcSEcCtD
Naproxen—Sinusitis—Epirubicin—peripheral nervous system neoplasm	4.84e-05	0.00023	CcSEcCtD
Naproxen—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	4.84e-05	0.00023	CcSEcCtD
Naproxen—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	4.83e-05	0.00023	CcSEcCtD
Naproxen—Nausea—Dactinomycin—peripheral nervous system neoplasm	4.82e-05	0.000229	CcSEcCtD
Naproxen—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	4.82e-05	0.000229	CcSEcCtD
Naproxen—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	4.8e-05	0.000228	CcSEcCtD
Naproxen—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	4.8e-05	0.000228	CcSEcCtD
Naproxen—Dizziness—Vincristine—peripheral nervous system neoplasm	4.8e-05	0.000228	CcSEcCtD
Naproxen—Vomiting—Alitretinoin—peripheral nervous system neoplasm	4.78e-05	0.000228	CcSEcCtD
Naproxen—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	4.78e-05	0.000227	CcSEcCtD
Naproxen—Rash—Alitretinoin—peripheral nervous system neoplasm	4.74e-05	0.000226	CcSEcCtD
Naproxen—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	4.74e-05	0.000225	CcSEcCtD
Naproxen—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	4.74e-05	0.000225	CcSEcCtD
Naproxen—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	4.72e-05	0.000225	CcSEcCtD
Naproxen—Headache—Alitretinoin—peripheral nervous system neoplasm	4.71e-05	0.000224	CcSEcCtD
Naproxen—Renal failure—Doxorubicin—peripheral nervous system neoplasm	4.7e-05	0.000223	CcSEcCtD
Naproxen—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	4.68e-05	0.000223	CcSEcCtD
Naproxen—Urticaria—Etoposide—peripheral nervous system neoplasm	4.67e-05	0.000222	CcSEcCtD
Naproxen—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	4.66e-05	0.000221	CcSEcCtD
Naproxen—Jaundice—Doxorubicin—peripheral nervous system neoplasm	4.66e-05	0.000221	CcSEcCtD
Naproxen—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	4.66e-05	0.000221	CcSEcCtD
Naproxen—Rhinitis—Epirubicin—peripheral nervous system neoplasm	4.65e-05	0.000221	CcSEcCtD
Naproxen—Abdominal pain—Etoposide—peripheral nervous system neoplasm	4.64e-05	0.000221	CcSEcCtD
Naproxen—Body temperature increased—Etoposide—peripheral nervous system neoplasm	4.64e-05	0.000221	CcSEcCtD
Naproxen—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	4.64e-05	0.000221	CcSEcCtD
Naproxen—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	4.64e-05	0.000221	CcSEcCtD
Naproxen—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	4.63e-05	0.00022	CcSEcCtD
Naproxen—Hepatitis—Epirubicin—peripheral nervous system neoplasm	4.63e-05	0.00022	CcSEcCtD
Naproxen—Vomiting—Vincristine—peripheral nervous system neoplasm	4.61e-05	0.000219	CcSEcCtD
Naproxen—Asthenia—Cisplatin—peripheral nervous system neoplasm	4.6e-05	0.000219	CcSEcCtD
Naproxen—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	4.6e-05	0.000219	CcSEcCtD
Naproxen—Sweating—Doxorubicin—peripheral nervous system neoplasm	4.58e-05	0.000218	CcSEcCtD
Naproxen—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	4.58e-05	0.000218	CcSEcCtD
Naproxen—Rash—Vincristine—peripheral nervous system neoplasm	4.57e-05	0.000217	CcSEcCtD
Naproxen—Dermatitis—Vincristine—peripheral nervous system neoplasm	4.57e-05	0.000217	CcSEcCtD
Naproxen—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	4.57e-05	0.000217	CcSEcCtD
Naproxen—Haematuria—Doxorubicin—peripheral nervous system neoplasm	4.55e-05	0.000217	CcSEcCtD
Naproxen—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	4.55e-05	0.000217	CcSEcCtD
Naproxen—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	4.54e-05	0.000216	CcSEcCtD
Naproxen—Headache—Vincristine—peripheral nervous system neoplasm	4.54e-05	0.000216	CcSEcCtD
Naproxen—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	4.52e-05	0.000215	CcSEcCtD
Naproxen—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	4.51e-05	0.000214	CcSEcCtD
Naproxen—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	4.48e-05	0.000213	CcSEcCtD
Naproxen—Nausea—Alitretinoin—peripheral nervous system neoplasm	4.47e-05	0.000213	CcSEcCtD
Naproxen—Visual impairment—Epirubicin—peripheral nervous system neoplasm	4.47e-05	0.000212	CcSEcCtD
Naproxen—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	4.46e-05	0.000212	CcSEcCtD
Naproxen—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	4.39e-05	0.000209	CcSEcCtD
Naproxen—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	4.38e-05	0.000208	CcSEcCtD
Naproxen—Eye disorder—Epirubicin—peripheral nervous system neoplasm	4.33e-05	0.000206	CcSEcCtD
Naproxen—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	4.33e-05	0.000206	CcSEcCtD
Naproxen—Tinnitus—Epirubicin—peripheral nervous system neoplasm	4.32e-05	0.000205	CcSEcCtD
Naproxen—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	4.31e-05	0.000205	CcSEcCtD
Naproxen—Nausea—Vincristine—peripheral nervous system neoplasm	4.31e-05	0.000205	CcSEcCtD
Naproxen—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	4.3e-05	0.000205	CcSEcCtD
Naproxen—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	4.3e-05	0.000204	CcSEcCtD
Naproxen—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	4.29e-05	0.000204	CcSEcCtD
Naproxen—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	4.29e-05	0.000204	CcSEcCtD
Naproxen—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	4.26e-05	0.000202	CcSEcCtD
Naproxen—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	4.23e-05	0.000201	CcSEcCtD
Naproxen—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	4.22e-05	0.000201	CcSEcCtD
Naproxen—Asthenia—Etoposide—peripheral nervous system neoplasm	4.21e-05	0.0002	CcSEcCtD
Naproxen—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	4.21e-05	0.0002	CcSEcCtD
Naproxen—Angiopathy—Epirubicin—peripheral nervous system neoplasm	4.2e-05	0.0002	CcSEcCtD
Naproxen—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	4.2e-05	0.0002	CcSEcCtD
Naproxen—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	4.19e-05	0.000199	CcSEcCtD
Naproxen—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	4.18e-05	0.000199	CcSEcCtD
Naproxen—Chills—Epirubicin—peripheral nervous system neoplasm	4.16e-05	0.000198	CcSEcCtD
Naproxen—Pruritus—Etoposide—peripheral nervous system neoplasm	4.16e-05	0.000198	CcSEcCtD
Naproxen—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	4.14e-05	0.000197	CcSEcCtD
Naproxen—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	4.13e-05	0.000196	CcSEcCtD
Naproxen—Alopecia—Epirubicin—peripheral nervous system neoplasm	4.1e-05	0.000195	CcSEcCtD
Naproxen—Vomiting—Cisplatin—peripheral nervous system neoplasm	4.08e-05	0.000194	CcSEcCtD
Naproxen—Mental disorder—Epirubicin—peripheral nervous system neoplasm	4.06e-05	0.000193	CcSEcCtD
Naproxen—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	4.05e-05	0.000193	CcSEcCtD
Naproxen—Rash—Cisplatin—peripheral nervous system neoplasm	4.04e-05	0.000192	CcSEcCtD
Naproxen—Dermatitis—Cisplatin—peripheral nervous system neoplasm	4.04e-05	0.000192	CcSEcCtD
Naproxen—Erythema—Epirubicin—peripheral nervous system neoplasm	4.03e-05	0.000192	CcSEcCtD
Naproxen—Malnutrition—Epirubicin—peripheral nervous system neoplasm	4.03e-05	0.000192	CcSEcCtD
Naproxen—Diarrhoea—Etoposide—peripheral nervous system neoplasm	4.02e-05	0.000191	CcSEcCtD
Naproxen—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	4.01e-05	0.000191	CcSEcCtD
Naproxen—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	4e-05	0.00019	CcSEcCtD
Naproxen—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	3.98e-05	0.000189	CcSEcCtD
Naproxen—Flatulence—Epirubicin—peripheral nervous system neoplasm	3.98e-05	0.000189	CcSEcCtD
Naproxen—Tension—Epirubicin—peripheral nervous system neoplasm	3.96e-05	0.000188	CcSEcCtD
Naproxen—Nervousness—Epirubicin—peripheral nervous system neoplasm	3.92e-05	0.000186	CcSEcCtD
Naproxen—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	3.89e-05	0.000185	CcSEcCtD
Naproxen—Dizziness—Etoposide—peripheral nervous system neoplasm	3.88e-05	0.000185	CcSEcCtD
Naproxen—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	3.88e-05	0.000184	CcSEcCtD
Naproxen—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	3.87e-05	0.000184	CcSEcCtD
Naproxen—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	3.86e-05	0.000184	CcSEcCtD
Naproxen—Chills—Doxorubicin—peripheral nervous system neoplasm	3.85e-05	0.000183	CcSEcCtD
Naproxen—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	3.83e-05	0.000182	CcSEcCtD
Naproxen—Nausea—Cisplatin—peripheral nervous system neoplasm	3.81e-05	0.000181	CcSEcCtD
Naproxen—Vision blurred—Epirubicin—peripheral nervous system neoplasm	3.8e-05	0.000181	CcSEcCtD
Naproxen—Alopecia—Doxorubicin—peripheral nervous system neoplasm	3.79e-05	0.00018	CcSEcCtD
Naproxen—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	3.76e-05	0.000179	CcSEcCtD
Naproxen—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	3.74e-05	0.000178	CcSEcCtD
Naproxen—Vomiting—Etoposide—peripheral nervous system neoplasm	3.73e-05	0.000178	CcSEcCtD
Naproxen—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	3.73e-05	0.000177	CcSEcCtD
Naproxen—Erythema—Doxorubicin—peripheral nervous system neoplasm	3.73e-05	0.000177	CcSEcCtD
Naproxen—Anaemia—Epirubicin—peripheral nervous system neoplasm	3.73e-05	0.000177	CcSEcCtD
Naproxen—Rash—Etoposide—peripheral nervous system neoplasm	3.7e-05	0.000176	CcSEcCtD
Naproxen—Dermatitis—Etoposide—peripheral nervous system neoplasm	3.7e-05	0.000176	CcSEcCtD
Naproxen—Headache—Etoposide—peripheral nervous system neoplasm	3.68e-05	0.000175	CcSEcCtD
Naproxen—Flatulence—Doxorubicin—peripheral nervous system neoplasm	3.68e-05	0.000175	CcSEcCtD
Naproxen—Tension—Doxorubicin—peripheral nervous system neoplasm	3.66e-05	0.000174	CcSEcCtD
Naproxen—Malaise—Epirubicin—peripheral nervous system neoplasm	3.64e-05	0.000173	CcSEcCtD
Naproxen—Nervousness—Doxorubicin—peripheral nervous system neoplasm	3.63e-05	0.000172	CcSEcCtD
Naproxen—Vertigo—Epirubicin—peripheral nervous system neoplasm	3.62e-05	0.000172	CcSEcCtD
Naproxen—Syncope—Epirubicin—peripheral nervous system neoplasm	3.62e-05	0.000172	CcSEcCtD
Naproxen—Leukopenia—Epirubicin—peripheral nervous system neoplasm	3.61e-05	0.000172	CcSEcCtD
Naproxen—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	3.59e-05	0.000171	CcSEcCtD
Naproxen—Palpitations—Epirubicin—peripheral nervous system neoplasm	3.57e-05	0.00017	CcSEcCtD
Naproxen—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	3.55e-05	0.000169	CcSEcCtD
Naproxen—Cough—Epirubicin—peripheral nervous system neoplasm	3.52e-05	0.000167	CcSEcCtD
Naproxen—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	3.52e-05	0.000167	CcSEcCtD
Naproxen—Convulsion—Epirubicin—peripheral nervous system neoplasm	3.5e-05	0.000166	CcSEcCtD
Naproxen—Nausea—Etoposide—peripheral nervous system neoplasm	3.49e-05	0.000166	CcSEcCtD
Naproxen—Hypertension—Epirubicin—peripheral nervous system neoplasm	3.48e-05	0.000166	CcSEcCtD
Naproxen—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	3.46e-05	0.000165	CcSEcCtD
Naproxen—Anaemia—Doxorubicin—peripheral nervous system neoplasm	3.45e-05	0.000164	CcSEcCtD
Naproxen—Myalgia—Epirubicin—peripheral nervous system neoplasm	3.43e-05	0.000163	CcSEcCtD
Naproxen—Chest pain—Epirubicin—peripheral nervous system neoplasm	3.43e-05	0.000163	CcSEcCtD
Naproxen—Arthralgia—Epirubicin—peripheral nervous system neoplasm	3.43e-05	0.000163	CcSEcCtD
Naproxen—Anxiety—Epirubicin—peripheral nervous system neoplasm	3.42e-05	0.000163	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	3.41e-05	0.000162	CcSEcCtD
Naproxen—Discomfort—Epirubicin—peripheral nervous system neoplasm	3.39e-05	0.000161	CcSEcCtD
Naproxen—Malaise—Doxorubicin—peripheral nervous system neoplasm	3.37e-05	0.00016	CcSEcCtD
Naproxen—Dry mouth—Epirubicin—peripheral nervous system neoplasm	3.36e-05	0.00016	CcSEcCtD
Naproxen—Vertigo—Doxorubicin—peripheral nervous system neoplasm	3.35e-05	0.000159	CcSEcCtD
Naproxen—Syncope—Doxorubicin—peripheral nervous system neoplasm	3.35e-05	0.000159	CcSEcCtD
Naproxen—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	3.34e-05	0.000159	CcSEcCtD
Naproxen—Confusional state—Epirubicin—peripheral nervous system neoplasm	3.32e-05	0.000158	CcSEcCtD
Naproxen—Palpitations—Doxorubicin—peripheral nervous system neoplasm	3.3e-05	0.000157	CcSEcCtD
Naproxen—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	3.29e-05	0.000157	CcSEcCtD
Naproxen—Oedema—Epirubicin—peripheral nervous system neoplasm	3.29e-05	0.000157	CcSEcCtD
Naproxen—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	3.28e-05	0.000156	CcSEcCtD
Naproxen—Infection—Epirubicin—peripheral nervous system neoplasm	3.27e-05	0.000156	CcSEcCtD
Naproxen—Cough—Doxorubicin—peripheral nervous system neoplasm	3.26e-05	0.000155	CcSEcCtD
Naproxen—Shock—Epirubicin—peripheral nervous system neoplasm	3.24e-05	0.000154	CcSEcCtD
Naproxen—Convulsion—Doxorubicin—peripheral nervous system neoplasm	3.23e-05	0.000154	CcSEcCtD
Naproxen—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	3.23e-05	0.000154	CcSEcCtD
Naproxen—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	3.22e-05	0.000153	CcSEcCtD
Naproxen—Hypertension—Doxorubicin—peripheral nervous system neoplasm	3.22e-05	0.000153	CcSEcCtD
Naproxen—Tachycardia—Epirubicin—peripheral nervous system neoplasm	3.21e-05	0.000153	CcSEcCtD
Naproxen—Skin disorder—Epirubicin—peripheral nervous system neoplasm	3.2e-05	0.000152	CcSEcCtD
Naproxen—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	3.18e-05	0.000151	CcSEcCtD
Naproxen—Myalgia—Doxorubicin—peripheral nervous system neoplasm	3.18e-05	0.000151	CcSEcCtD
Naproxen—Chest pain—Doxorubicin—peripheral nervous system neoplasm	3.18e-05	0.000151	CcSEcCtD
Naproxen—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	3.18e-05	0.000151	CcSEcCtD
Naproxen—Anxiety—Doxorubicin—peripheral nervous system neoplasm	3.17e-05	0.000151	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	3.16e-05	0.00015	CcSEcCtD
Naproxen—Discomfort—Doxorubicin—peripheral nervous system neoplasm	3.14e-05	0.000149	CcSEcCtD
Naproxen—Anorexia—Epirubicin—peripheral nervous system neoplasm	3.14e-05	0.000149	CcSEcCtD
Naproxen—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	3.11e-05	0.000148	CcSEcCtD
Naproxen—Hypotension—Epirubicin—peripheral nervous system neoplasm	3.08e-05	0.000146	CcSEcCtD
Naproxen—Confusional state—Doxorubicin—peripheral nervous system neoplasm	3.07e-05	0.000146	CcSEcCtD
Naproxen—Oedema—Doxorubicin—peripheral nervous system neoplasm	3.05e-05	0.000145	CcSEcCtD
Naproxen—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	3.05e-05	0.000145	CcSEcCtD
Naproxen—Infection—Doxorubicin—peripheral nervous system neoplasm	3.03e-05	0.000144	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	3e-05	0.000143	CcSEcCtD
Naproxen—Shock—Doxorubicin—peripheral nervous system neoplasm	3e-05	0.000143	CcSEcCtD
Naproxen—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	2.99e-05	0.000142	CcSEcCtD
Naproxen—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	2.98e-05	0.000142	CcSEcCtD
Naproxen—Insomnia—Epirubicin—peripheral nervous system neoplasm	2.98e-05	0.000142	CcSEcCtD
Naproxen—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	2.97e-05	0.000141	CcSEcCtD
Naproxen—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	2.96e-05	0.000141	CcSEcCtD
Naproxen—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	2.96e-05	0.000141	CcSEcCtD
Naproxen—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	2.95e-05	0.00014	CcSEcCtD
Naproxen—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	2.94e-05	0.00014	CcSEcCtD
Naproxen—Somnolence—Epirubicin—peripheral nervous system neoplasm	2.93e-05	0.000139	CcSEcCtD
Naproxen—Anorexia—Doxorubicin—peripheral nervous system neoplasm	2.9e-05	0.000138	CcSEcCtD
Naproxen—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	2.9e-05	0.000138	CcSEcCtD
Naproxen—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	2.86e-05	0.000136	CcSEcCtD
Naproxen—Hypotension—Doxorubicin—peripheral nervous system neoplasm	2.85e-05	0.000135	CcSEcCtD
Naproxen—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	2.84e-05	0.000135	CcSEcCtD
Naproxen—Fatigue—Epirubicin—peripheral nervous system neoplasm	2.84e-05	0.000135	CcSEcCtD
Naproxen—Constipation—Epirubicin—peripheral nervous system neoplasm	2.82e-05	0.000134	CcSEcCtD
Naproxen—Pain—Epirubicin—peripheral nervous system neoplasm	2.82e-05	0.000134	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	2.78e-05	0.000132	CcSEcCtD
Naproxen—Insomnia—Doxorubicin—peripheral nervous system neoplasm	2.76e-05	0.000131	CcSEcCtD
Naproxen—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	2.74e-05	0.00013	CcSEcCtD
Naproxen—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	2.72e-05	0.000129	CcSEcCtD
Naproxen—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	2.71e-05	0.000129	CcSEcCtD
Naproxen—Somnolence—Doxorubicin—peripheral nervous system neoplasm	2.71e-05	0.000129	CcSEcCtD
Naproxen—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	2.69e-05	0.000128	CcSEcCtD
Naproxen—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	2.68e-05	0.000128	CcSEcCtD
Naproxen—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	2.65e-05	0.000126	CcSEcCtD
Naproxen—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	2.63e-05	0.000125	CcSEcCtD
Naproxen—Fatigue—Doxorubicin—peripheral nervous system neoplasm	2.63e-05	0.000125	CcSEcCtD
Naproxen—Urticaria—Epirubicin—peripheral nervous system neoplasm	2.62e-05	0.000124	CcSEcCtD
Naproxen—Pain—Doxorubicin—peripheral nervous system neoplasm	2.61e-05	0.000124	CcSEcCtD
Naproxen—Constipation—Doxorubicin—peripheral nervous system neoplasm	2.61e-05	0.000124	CcSEcCtD
Naproxen—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	2.6e-05	0.000124	CcSEcCtD
Naproxen—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	2.6e-05	0.000124	CcSEcCtD
Naproxen—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	2.51e-05	0.000119	CcSEcCtD
Naproxen—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	2.49e-05	0.000118	CcSEcCtD
Naproxen—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	2.43e-05	0.000115	CcSEcCtD
Naproxen—Urticaria—Doxorubicin—peripheral nervous system neoplasm	2.42e-05	0.000115	CcSEcCtD
Naproxen—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	2.41e-05	0.000115	CcSEcCtD
Naproxen—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	2.41e-05	0.000115	CcSEcCtD
Naproxen—Asthenia—Epirubicin—peripheral nervous system neoplasm	2.36e-05	0.000112	CcSEcCtD
Naproxen—Pruritus—Epirubicin—peripheral nervous system neoplasm	2.33e-05	0.000111	CcSEcCtD
Naproxen—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	2.25e-05	0.000107	CcSEcCtD
Naproxen—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	2.24e-05	0.000107	CcSEcCtD
Naproxen—Asthenia—Doxorubicin—peripheral nervous system neoplasm	2.19e-05	0.000104	CcSEcCtD
Naproxen—Dizziness—Epirubicin—peripheral nervous system neoplasm	2.18e-05	0.000104	CcSEcCtD
Naproxen—Pruritus—Doxorubicin—peripheral nervous system neoplasm	2.16e-05	0.000102	CcSEcCtD
Naproxen—Vomiting—Epirubicin—peripheral nervous system neoplasm	2.09e-05	9.95e-05	CcSEcCtD
Naproxen—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	2.08e-05	9.91e-05	CcSEcCtD
Naproxen—Rash—Epirubicin—peripheral nervous system neoplasm	2.08e-05	9.87e-05	CcSEcCtD
Naproxen—Dermatitis—Epirubicin—peripheral nervous system neoplasm	2.07e-05	9.86e-05	CcSEcCtD
Naproxen—Headache—Epirubicin—peripheral nervous system neoplasm	2.06e-05	9.81e-05	CcSEcCtD
Naproxen—Dizziness—Doxorubicin—peripheral nervous system neoplasm	2.01e-05	9.58e-05	CcSEcCtD
Naproxen—Nausea—Epirubicin—peripheral nervous system neoplasm	1.96e-05	9.3e-05	CcSEcCtD
Naproxen—Vomiting—Doxorubicin—peripheral nervous system neoplasm	1.94e-05	9.21e-05	CcSEcCtD
Naproxen—Rash—Doxorubicin—peripheral nervous system neoplasm	1.92e-05	9.13e-05	CcSEcCtD
Naproxen—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	1.92e-05	9.13e-05	CcSEcCtD
Naproxen—Headache—Doxorubicin—peripheral nervous system neoplasm	1.91e-05	9.08e-05	CcSEcCtD
Naproxen—Nausea—Doxorubicin—peripheral nervous system neoplasm	1.81e-05	8.6e-05	CcSEcCtD
